Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Jinming Zhang"'
Autor:
Andressa Dias Costa, Sara A. Väyrynen, Akhil Chawla, Jinming Zhang, Juha P. Väyrynen, Mai Chan Lau, Hannah L. Williams, Chen Yuan, Vicente Morales-Oyarvide, Dalia Elganainy, Harshabad Singh, James M. Cleary, Kimberly Perez, Kimmie Ng, William Freed-Pastor, Joseph D. Mancias, Stephanie K. Dougan, Jiping Wang, Douglas A. Rubinson, Richard F. Dunne, Margaret M. Kozak, Lauren Brais, Emma Reilly, Thomas Clancy, David C. Linehan, Daniel T. Chang, Aram F. Hezel, Albert C. Koong, Andrew J. Aguirre, Brian M. Wolpin, Jonathan A. Nowak
Publikováno v:
Clin Cancer Res
Purpose: Neoadjuvant chemotherapy is increasingly administered to patients with resectable or borderline resectable pancreatic ductal adenocarcinoma (PDAC), yet its impact on the tumor immune microenvironment is incompletely understood. Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753ddec4144c9af320945c1943c5debd
https://europepmc.org/articles/PMC9999119/
https://europepmc.org/articles/PMC9999119/
Autor:
Pengfei Gu, Bin Ling, Weike Ma, Jinming Zhang, Wei Zhang, Yu Zeng, Yu Liu, Jiadong Chi, Xianhui Ruan, Xiangqian Zheng, Songfeng Wei, Ming Gao
Publikováno v:
BMC Cancer. 22
Background The linkage between IDO2 expression and cancer progression is still unclear, particularly in medullary thyroid carcinoma (MTC). Our purpose is to unveil the potential correlations between IDO2 status, clinical-pathological parameters, pati
Autor:
Huan Zhang, Jing Xian, Xiao Wang, Huan Gu, Jinming Zhang, Jingjing Li, Chen Zhang, Chaomei Fu
Publikováno v:
ACS Applied Materials & Interfaces. 13:33948-33961
Although magnolol (Mag), an anti-inflammatory natural compound, has been demonstrated to play protective effects on ulcerative colitis (UC), its application as an alternative therapeutic reagent for UC treatment is still greatly impeded due to its po
Autor:
Jin-Feng Shi, Huan Gu, Jiaqi Ma, Yali Ren, Yihan Wu, Jinming Zhang, Xi Luo, Zhixing Cao, Chaomei Fu, Jiaxin Li
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-22 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background The toxicity and inefficient delivery of triptolide (TPL) in tumor therapy have greatly limited the clinical application. Thus, we fabricated a CD44-targeting and tumor microenvironment pH/redox-sensitive nanosystem composed of hyaluronic
Publikováno v:
Bio-medical materials and engineering. 33(6)
BACKGROUND: With the increasing aging of population, the incidence rate of diseases such as fracture and osteoporosis has been increasing. The demand for implant in Department of orthopedics has increased. The elastic modulus of the existing solid me
Publikováno v:
Nuclear medicine communications. 43(6)
Fluorine 18 (18F)-2-(3-{1-Carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (DCFPyL) is an early 18F-labeled prostate-specific membrane antigen (PSMA) targeted PET tracer that has shown promise in the diagnosti
Publikováno v:
Clinical nuclear medicine. 47(6)
To evaluate the diagnostic potential of decision-tree model of diffusion kurtosis imaging (DKI) and 11C-methionine (11C-MET) PET, for the differentiation of radiotherapy (RT) injury from glioblastoma recurrence.Eighty-six glioblastoma cases with susp
Publikováno v:
Frontiers in endocrinology. 13
BackgroundLenvatinib has shown promising efficacy in targeted therapies that have been tested to treat anaplastic thyroid carcinoma (ATC) in both preclinical and clinical studies. The aim of this study was to evaluate the efficacy and safety of lenva
Publikováno v:
Langenbeck's archives of surgery. 407(7)
The extent of thyroid surgery and cervical lymph node dissection of unilateral sporadic medullary thyroid carcinoma (sMTC) is still controversial, and the aim of this study was to investigate whether hemithyroidectomy was adequate as a locally curati
Autor:
Jingjing, Li, Yanfen, Cheng, Renkai, Li, Xiaoping, Wu, Chengwen, Zheng, Polly Ho-Ting, Shiu, Jacqueline Cho-Ki, Chan, Panthakarn, Rangsinth, Conghui, Liu, Susan Wai-Sum, Leung, Simon Ming-Yuen, Lee, Chen, Zhang, Chaomei, Fu, Jinming, Zhang, Timothy Man-Yau, Cheung, George Pak-Heng, Leung
Publikováno v:
Oxidative medicine and cellular longevity. 2022
Clinical outcomes for doxorubicin (Dox) are limited by its cardiotoxicity but a combination of Dox and agents with cardioprotective activities is an effective strategy to improve its therapeutic outcome. Natural products provide abundant resources to